Member Info for BOJO2020

Better question. How many times has he done what he did with GGP

No cost to vote on ii

Hi Ben,

Callum made a good point about 6 months ago. Aussie insti's will want some of this. Most likley when ASX listed. Guess they were having a look a while back but circumstances were not right and it would not surprise me if SD has been chatting them up.

Starbright you make a strong argument but it is what it is now so basically a mute point. Last week is a long time in investing...

They have had trouble loading trades and keeping up to date on some investments. Need to put another 50p in the slot...

Largely people need validation of their ideas and perceptions by other people instead of understanding for themselves. So just ignore.

GG,

Have to buy in at some point if that is your intention. Calculated risk so never gonna be a perfect entry

ATB

Yes 10 bag territory…

And well all breakeven 😂

TGTD said,

🥕 why do you feel the need to keep copying and posting the same stuff that's months old if not years over and over again!

...

Thanks Dipp

JungleB,

Possible consolidation but it makes no material difference. Remember the strong fundamentals here. Strong free cash flow very soon. No need for any smoke and mirrors here as opposed other (former) peers. IMO.

Easy on ii

Analytical sensitivity and specificity for epithelial, mesenchymal and blood lineage markers**

They do look impressive when you scroll down the page

Currently at 3.7 to buy. The 4p's are just the MM posting tiny trades to draw you in

EE,

Do you think these odd transactions like the delayed prints etc are what are called beyond level 2? By which I mean we don’t really have anyway of knowing but the MM do as they see other levels.

Can any of you, ‘investors,’ explain how the cheapest print of the day on Friday (delayed) was a buy? Does that mean there were no sells on Friday as all other transactions were of higher value?

Thanks in advance cus I dunt understand how all thems pence and pounds fings work.

No rush…

Buys over 17.40 for sure. Maybe 17.20 too. Sells have been 17 and no trade to sell this AM. IMO

Just listening to the 23 AGM. A question was asked if SCIB1 could still have legs as a mono therapy. (This brings me to your point ViolinDog) Lindy answered that the success in the monotherapy came from resected patients and that now checkpoints are available for that cohort Scancell would probably just go with checkpoints. So clinically Scancell have moved on with checkpoints. So in my opinion the old monotherapy data has served its purpose, but lovely to see those patients alive and kicking!

If one of the more experienced scientific posters feels the need to refine the points I make or correct them, I am happy for them to do so.

Yes, Lindy has referred to these patients and basically said those that are in PFS are still doing well. It was in one of the presentations or an Proactive interview but seem to remember her saying this in the last 12 months. Maybe one of the other can confirm but Scancell are under no obligation to continue monitoring past PFS

LD does make minute slips when put in formal broadcasting situations. This makes her no less an amazing scientist, but still human like the rest of us. No doubt the issue is exacerbated by the voids in news for the main part which results in the tendency of everyone to hang on to her every word. Common sense suggests it's probably still 85% and of little greater significance if it is 86%.